J Cancer 2020; 11(4):990-996. doi:10.7150/jca.29105 This issue

Research Paper

EIF4E regulates STEAP1 expression in peritoneal metastasis

Jun-nan Jiang, Yuan-yu Wu, Xue-dong Fang, Fu-jian Ji

Department of Gastrointestinal Colorectal and Anal Surgery, The China-Japan Union Hospital of Jilin University, Changchun 130033, China.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Jiang Jn, Wu Yy, Fang Xd, Ji Fj. EIF4E regulates STEAP1 expression in peritoneal metastasis. J Cancer 2020; 11(4):990-996. doi:10.7150/jca.29105. Available from https://www.jcancer.org/v11p0990.htm

File import instruction


Gastric cancer is the most prominent form of malignancy in China, and the high mortality associated with it is mostly due to peritoneal metastasis. We have previously elucidated that the RNA-binding protein poly r(C) binding protein 1 (PCBP1) and miR-3978 function as repressors of peritoneal metastasis, partially by downregulation of six-transmembrane epithelial antigen of the prostate 1 (STEAP1). We now show that STEAP1 is regulated at the level of cap-dependent translation initiation by phosphorylated eIF4E. Chemically inhibiting phosphorylation of eIF4E or genetic ablation of phosphorylated eIF4E inhibit translational upregulation of STEAP1 in the peritoneal metastasis mimicking cell line MKN45 in comparison to the normal mesothelial cell line HMrSV5. Thus phosphorylation of eIF4E is required for peritoneal metastasis of gastric cancer via translational control of STEAP1. Chemical inhibitors targeting phosphorylation of eIF4E or its interaction with the translation initiation complex thus might prove effective in treating patients with peritoneal metastasis.

Keywords: STEAP1, gastric cancer, peritoneal metastases, eIF4E.